PT Millennium Pharmacon International Tbk (ISX:SDPC) Growth Rank: 6 (As of Aug. 22, 2026) — 50% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SDPC PT Millennium Pharmacon International Tbk ISX:SDPC
78 GF Score
Price Rp192.00
GF Value Rp170.10
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is PT Millennium Pharmacon International Tbk Growth Rank?

PT Millennium Pharmacon International Tbk ISX:SDPC +1.05% 78 Growth Rank is 6 as of Aug. 22, 2026, which is 50% above its 10-year median of 4.00. GuruFocus rates ISX:SDPC with a GF Score™ of 78/100 and a GF Value™ of Rp170.10 (Modestly Overvalued). The stock has 6 warning signs investors should review.

PT Millennium Pharmacon International Tbk has the Growth Rank of 6.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

PT Millennium Pharmacon International Tbk Growth Rank Related Terms

ISX:SDPC vs MCK, COR, CAH: Growth Rank Comparison

For the Medical Distribution subindustry, PT Millennium Pharmacon International Tbk's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Millennium Pharmacon International Tbk Growth Rank vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Millennium Pharmacon International Tbk's Growth Rank distribution charts can be found below:

* The bar in red indicates where PT Millennium Pharmacon International Tbk's Growth Rank falls into.


ISX:SDPC
78GF Score
PT Millennium Pharmacon International Tbk ISX:SDPC
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 6 mean?
PT Millennium Pharmacon International Tbk (ISX:SDPC) has a Growth Rank of 6 as of Aug. 22, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on PT Millennium Pharmacon International Tbk and its competitors. This is 50% above median its historical median of 4.00. Over the past decade, PT Millennium Pharmacon International Tbk's Growth Rank has ranged from 2.00 to 8.00.
Is PT Millennium Pharmacon International Tbk's Growth Rank too high?
PT Millennium Pharmacon International Tbk's current Growth Rank of 6 is 50% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. Overall, PT Millennium Pharmacon International Tbk has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Millennium Pharmacon International Tbk's Growth Rank compare to MCK and COR?
PT Millennium Pharmacon International Tbk's Growth Rank of 6 can be compared against companies in the Medical Distribution industry. Historically, PT Millennium Pharmacon International Tbk's own Growth Rank has ranged from 2.00 to 8.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Distribution company?
A good Growth Rank depends on the Medical Distribution industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on PT Millennium Pharmacon International Tbk and its competitors. PT Millennium Pharmacon International Tbk's current Growth Rank is 6, which is 50% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Millennium Pharmacon International Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk (ISX:SDPC) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp170.10, compared to a current price of Rp192.00 — trading 12.9% above its estimated fair value. The current Growth Rank is 6, which is 50% above median its 10-year median of 4.00. PT Millennium Pharmacon International Tbk's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For PT Millennium Pharmacon International Tbk (ISX:SDPC), the current Growth Rank is 6 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Millennium Pharmacon International Tbk (ISX:SDPC) Overvalued in 2026?

Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk stock appears to be overvalued. The current stock price of Rp192.00 is trading 12.9% above its estimated GF Value™ of Rp170.10. GuruFocus considers PT Millennium Pharmacon International Tbk to be Modestly Overvalued.

Key valuation signals for ISX:SDPC:

  • Growth Rank: 6 (50% above median its 10-year median of 4.00)
  • GF Value™: Rp170.10 vs. price of Rp192.00 (12.9% above fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the ISX:SDPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Millennium Pharmacon International Tbk Business Description

Address Jl. Sultan Iskandar Muda No 18/Jl. Bungur No. 1, Crown Bungur Arteri Lantai 2-4, Kel. Kebayoran Lama Selatan, Kec. Kebayoran Lama, South Jakarta, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The group's operating segments are Prescription medicine, Non-prescription medicine, Medical Disposables, and others, of which the majority of revenue is derived from the Prescription Medicine segment. The company's geographical segments are Jawa, Sumatra, Kalimantan, Sulawesi, and Bali & Lombok.
78GF Score

Get the complete analysis for ISX:SDPC

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp192.00
Price
Rp170.10
GF Value